Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iSpecimen Inc. (ISPC : NSDQ)
 
 • Company Description   
iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass.

Number of Employees: 46

 
 • Price / Volume Information   
Yesterday's Closing Price: $13.24 Daily Weekly Monthly
20 Day Moving Average: 15,194,422 shares
Shares Outstanding: 7.00 (millions)
Market Capitalization: $92.64 (millions)
Beta:
52 Week High: $28.98
52 Week Low: $4.75
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 109.49% 116.03%
12 Week 98.50% 96.53%
Year To Date % %
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
450 BEDFORD STREET SUITE 1010
-
LEXINGTON,MA 02420
USA
ph: 781-301-6700
fax: -
ispecimen@kcsa.com http://www.ispecimen.com
 
 • General Corporate Information   
Officers
Christopher Ianelli - Chief Executive Officer and President
Andrew L. Ross - Chairman
Jill Mullan - Chief Operating Officer; Secretary; Treasurer
Steven Gullans - Director
George (Bud) Scholl - Director

Peer Information
iSpecimen Inc. (CHCR)
iSpecimen Inc. (ESRX)
iSpecimen Inc. (MYDP)
iSpecimen Inc. (GBCS)
iSpecimen Inc. (LAXAF)
iSpecimen Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 45032V108
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/03/22
Share - Related Items
Shares Outstanding: 7.00
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $92.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 7.66
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 74.71%
Sales Growth
vs. Year Ago Period: 20.84%
vs. Previous Quarter: -6.37%
ROE
09/30/21 - -
06/30/21 - -
03/31/21 - -
ROA
09/30/21 - -
06/30/21 - -
03/31/21 - -
Current Ratio
09/30/21 - 7.08
06/30/21 - 2.86
03/31/21 - -
Quick Ratio
09/30/21 - 7.08
06/30/21 - 2.86
03/31/21 - -
Operating Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Net Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Pre-Tax Margin
09/30/21 - -
06/30/21 - -
03/31/21 - -
Book Value
09/30/21 - 1.73
06/30/21 - 1.64
03/31/21 - -
Inventory Turnover
09/30/21 - -
06/30/21 - -
03/31/21 - -
Debt-to-Equity
09/30/21 - 0.28
06/30/21 - 0.28
03/31/21 - -
Debt-to-Capital
09/30/21 - 22.09
06/30/21 - 21.93
03/31/21 - -
 

Powered by Zacks Investment Research ©